Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) reached a new 52-week high on Tuesday . The company traded as high as $1.54 and last traded at $1.50, with a volume of 11049 shares changing hands. The stock had previously closed at $1.51.
BioRestorative Therapies Price Performance
The firm’s 50-day moving average is $1.62 and its two-hundred day moving average is $1.60. The company has a market cap of $2.43 billion, a P/E ratio of -1.40 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
See Also
- Five stocks we like better than BioRestorative Therapies
- Insider Trades May Not Tell You What You Think
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Use Stock Screeners to Find Stocks
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
